 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Revvity |
| Street 1: | 940 Winter Street |
| Street 2: | |
| City: | Waltham |
| Province: | Massachusetts |
| Post Code: | 02451 |
| Country: | United States of America |
| Phone: | +1 781 663 6900 |
| Organization Email: | rbrignall@oxfordimmunotec.com |
| Web Site: | http://www.revvity.com/?utm_source=google&utm_medium=cpc&utm_campaign=BRD-REV-2023-EMEA-PaidSearch-SCH-EGM-ZZ&sfdc_id=7014V000002MwcZ&LS=PPC&adgroup=148440360626&ad=657736620221&keyword=revvity&gclid=CjwKCAjwoqGnBhAcEiwA |
| Other Online Presence: | http://www.tspot.com/uk/ |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | None |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | 03763278 |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Health |
| Organization Description: | |
| Revvity is an international developer and provider of end-to-end solutions designed to help scientists, researchers and clinicians solve the world’s greatest health challenges. As part of this commitment, Revvity has a dedicated TB business unit, Oxford Immunotec, tasked with developing novel TB diagnostics, as well as manufacturing and selling the T-SPOT®.TB test, and World Health Organization recommended diagnostic test for the detection of TB infection. Oxford Immunotec has sold over 20 million T-SPOT.TB tests in over 50 countries worldwide since its launch in 2002. It is the only ELISPOT-based test for TB infection to gain global regulatory approvals, including approval in the US, China and Japan. The T-SPOT.TB test is recommended by the WHO, and included on the WHO Model List of Essential In Vitro Diagnostics. In addition, Oxford Immunotec has a development team of 30 people, all dedicated to improving existing TB diagnostics, and developing novel TB diagnostics. Oxford Immunotec also has a manufacturing and quality team of nearly 50 people, dedicated to producing quality-controlled TB test kits that are used all over the world. Finally, Oxford Immunotec has Regulatory and Clinical teams committed to conducting clinical studies and gaining regulatory approvals for TB diagnostics. In terms of TB control, we are committed to educating and supporting countries in implementing and expanding latent TB screening, with the goal of supporting the eradication of TB. Further to this, we are currently developing innovative products to help solve the greatest clinical unmet needs within the TB space, for example, we have a focus on developing tests for active TB that do not require a sputum sample. |
|
| Do you know about the UNHLM declaration: | Yes |
Specializations / Areas of Work | |
|
Advocacy Delivery of health services and care Engaging political leaders and ensuring inclusive leadership Provision of drugs, diagnostics and commodities Research and Development Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 100 + |
| Number of part-time staff who are directly involved with TB: | 51 - 99 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| Revvity's TB business unit includes Oxford Diagnostic Laboratories. Oxford Diagnostic Laboratories is the UK's largest referral laboratory for analyses based on the T-SPOT technology. They provide screening for hospitals across the UK, as well as Public Health, incidents, and latent TB screening programmes. Of note, Oxford Diagnostic Laboratories has been supporting Public Health by conducting testing for TB detection in Ukrainian and Afghan refugees in the UK to minimise the spread of TB disease from higher burden countries during mass migration events. | |
Geographical Reach | |
| Which country is your headquarters located in: | United States of America |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Bangladesh Brazil Bulgaria Cameroon China France Germany Ghana Hungary India Indonesia Ireland Italy Japan Kenya Madagascar Maldives Netherlands Norway Philippines Poland Russian Federation Saudi Arabia Singapore South Africa Spain Sweden Thailand Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United States of America Viet Nam |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Annual World TB Day social media campaigns to encourage early detection and treatment of TB infection. Educating and supporting countries in developing plans to eradicate TB by offering tests for TB infection. Currently supporting the Maldives with their national strategy to end TB by 2025 by offering the T-SPOT.TB test to detect TB infection in high-risk groups. New Diagnostics: Developing new diagnostics with a focus on non-sputum based diagnostics to meet critical unmet need within the TB space. New TB Vaccines: We have a business unit called Certimmune which supports vaccine developers with T-cell based testing to help determine the efficacy of vaccines. We are hoping to partner with TB vaccine developers to provide valuable T cell based information, following the success of this approach with the COVID-19 vaccine development. Research: We support researchers by providing free of charge kits and scientific support for studies focusing on TB infection detection. We also provide educational grants for relevant congress attendance on an ad hoc application based basis. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | August 25, 2023 |
| Last updated: | August 25, 2023 |